<DOC>
	<DOCNO>NCT00540137</DOCNO>
	<brief_summary>The purpose study investigate possibility association change neurocognitive function , measure computerised test battery , use two different highly active antiretroviral therapy ( HAART ) regimens treatment naïve HIV-1 infected subject commence antiretroviral therapy .</brief_summary>
	<brief_title>The CogNaive Study : Assessing Changes Neurocognitive Function Treatment Naïve HIV-1 Positive Subjects</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>HIV1 infect male female Signed informed consent No previous antiretroviral treatment Males CD4+ lymphocyte count &lt; 400 cells/ųL female CD4+ lymphocyte count &lt; 250 cells/ųL Susceptible currently license nucleoside reverse transcriptase inhibitor ( NRTIs ) , nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) protease inhibitor ( PIs ) Existing neurological disease Hepatitis B hepatitis C coinfection Current history major depression psychosis Recent head injury Current alcohol abuse drug dependence Active opportunistic infection significant comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>Neurocognitive function</keyword>
	<keyword>Magnetic resonance spectroscopy</keyword>
	<keyword>HIV disease</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>